3.20.1 html 294 493 1 true 95 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.acelrx.com/20191231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.acelrx.com/20191231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.acelrx.com/20191231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://www.acelrx.com/20191231/role/statement-consolidated-statements-of-comprehensive-loss Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://www.acelrx.com/20191231/role/statement-consolidated-statements-of-stockholders-equity-deficit Consolidated Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.acelrx.com/20191231/role/statement-condensed-consolidated-statements-of-cash-flows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies Sheet http://www.acelrx.com/20191231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies Note 1 - Organization and Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Investments and Fair Value Measurement Sheet http://www.acelrx.com/20191231/role/statement-note-2-investments-and-fair-value-measurement Note 2 - Investments and Fair Value Measurement Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Inventories Sheet http://www.acelrx.com/20191231/role/statement-note-3-inventories Note 3 - Inventories Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Property and Equipment Sheet http://www.acelrx.com/20191231/role/statement-note-4-property-and-equipment Note 4 - Property and Equipment Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Revenue from Contracts with Customers Sheet http://www.acelrx.com/20191231/role/statement-note-5-revenue-from-contracts-with-customers Note 5 - Revenue from Contracts with Customers Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Long-term Debt Sheet http://www.acelrx.com/20191231/role/statement-note-6-longterm-debt- Note 6 - Long-term Debt Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Leases Sheet http://www.acelrx.com/20191231/role/statement-note-7-leases Note 7 - Leases Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Liability Related to Sale of Future Royalties Sheet http://www.acelrx.com/20191231/role/statement-note-8-liability-related-to-sale-of-future-royalties Note 8 - Liability Related to Sale of Future Royalties Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Warrants Sheet http://www.acelrx.com/20191231/role/statement-note-9-warrants Note 9 - Warrants Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Commitments and Contingencies Sheet http://www.acelrx.com/20191231/role/statement-note-10-commitments-and-contingencies Note 10 - Commitments and Contingencies Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Stockholders' Equity Sheet http://www.acelrx.com/20191231/role/statement-note-11-stockholders-equity- Note 11 - Stockholders' Equity Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Stock-based Compensation Sheet http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation Note 12 - Stock-based Compensation Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Net Loss Per Share of Common Stock Sheet http://www.acelrx.com/20191231/role/statement-note-13-net-loss-per-share-of-common-stock Note 13 - Net Loss Per Share of Common Stock Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Accrued Liabilities Sheet http://www.acelrx.com/20191231/role/statement-note-14-accrued-liabilities Note 14 - Accrued Liabilities Notes 20 false false R21.htm 020 - Disclosure - Note 15 - 401(k) Plan Sheet http://www.acelrx.com/20191231/role/statement-note-15-401k-plan Note 15 - 401(k) Plan Notes 21 false false R22.htm 021 - Disclosure - Note 16 - Income Taxes Sheet http://www.acelrx.com/20191231/role/statement-note-16-income-taxes Note 16 - Income Taxes Notes 22 false false R23.htm 022 - Disclosure - Note 17 - Subsequent Event Sheet http://www.acelrx.com/20191231/role/statement-note-17-subsequent-event Note 17 - Subsequent Event Notes 23 false false R24.htm 023 - Disclosure - Note 18 - Unaudited Quarterly Financial Data Sheet http://www.acelrx.com/20191231/role/statement-note-18-unaudited-quarterly-financial-data Note 18 - Unaudited Quarterly Financial Data Notes 24 false false R25.htm 024 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.acelrx.com/20191231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.acelrx.com/20191231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies 25 false false R26.htm 025 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables Note 1 - Organization and Summary of Significant Accounting Policies (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies 26 false false R27.htm 026 - Disclosure - Note 2 - Investments and Fair Value Measurement (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-2-investments-and-fair-value-measurement-tables Note 2 - Investments and Fair Value Measurement (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-2-investments-and-fair-value-measurement 27 false false R28.htm 027 - Disclosure - Note 3 - Inventories (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-3-inventories-tables Note 3 - Inventories (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-3-inventories 28 false false R29.htm 028 - Disclosure - Note 4 - Property and Equipment (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-4-property-and-equipment-tables Note 4 - Property and Equipment (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-4-property-and-equipment 29 false false R30.htm 029 - Disclosure - Note 5 - Revenue from Contracts with Customers (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-5-revenue-from-contracts-with-customers-tables Note 5 - Revenue from Contracts with Customers (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-5-revenue-from-contracts-with-customers 30 false false R31.htm 030 - Disclosure - Note 6 - Long-term Debt (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-6-longterm-debt-tables Note 6 - Long-term Debt (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-6-longterm-debt- 31 false false R32.htm 031 - Disclosure - Note 7 - Leases (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-7-leases-tables Note 7 - Leases (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-7-leases 32 false false R33.htm 032 - Disclosure - Note 8 - Liability Related to Sale of Future Royalties (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-8-liability-related-to-sale-of-future-royalties-tables Note 8 - Liability Related to Sale of Future Royalties (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-8-liability-related-to-sale-of-future-royalties 33 false false R34.htm 033 - Disclosure - Note 12 - Stock-based Compensation (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation-tables Note 12 - Stock-based Compensation (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation 34 false false R35.htm 034 - Disclosure - Note 13 - Net Loss Per Share of Common Stock (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-13-net-loss-per-share-of-common-stock-tables Note 13 - Net Loss Per Share of Common Stock (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-13-net-loss-per-share-of-common-stock 35 false false R36.htm 035 - Disclosure - Note 14 - Accrued Liabilities (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-14-accrued-liabilities-tables Note 14 - Accrued Liabilities (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-14-accrued-liabilities 36 false false R37.htm 036 - Disclosure - Note 16 - Income Taxes (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-16-income-taxes-tables Note 16 - Income Taxes (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-16-income-taxes 37 false false R38.htm 037 - Disclosure - Note 18 - Unaudited Quarterly Financial Data (Tables) Sheet http://www.acelrx.com/20191231/role/statement-note-18-unaudited-quarterly-financial-data-tables Note 18 - Unaudited Quarterly Financial Data (Tables) Tables http://www.acelrx.com/20191231/role/statement-note-18-unaudited-quarterly-financial-data 38 false false R39.htm 038 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables 39 false false R40.htm 039 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies - Adjustments for Adoption of New Lease Standard (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-adjustments-for-adoption-of-new-lease-standard-details Note 1 - Organization and Summary of Significant Accounting Policies - Adjustments for Adoption of New Lease Standard (Details) Details 40 false false R41.htm 040 - Disclosure - Note 2 - Investments and Fair Value Measurement (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-2-investments-and-fair-value-measurement-details-textual Note 2 - Investments and Fair Value Measurement (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-2-investments-and-fair-value-measurement-tables 41 false false R42.htm 041 - Disclosure - Note 2 - Investments and Fair Value Measurement - Summary of Cash, Cash Equivalents and Investments (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-2-investments-and-fair-value-measurement-summary-of-cash-cash-equivalents-and-investments-details Note 2 - Investments and Fair Value Measurement - Summary of Cash, Cash Equivalents and Investments (Details) Details 42 false false R43.htm 042 - Disclosure - Note 2 - Investments and Fair Value Measurement - Fair Value of Financial Assets and Liabilities by Level Within Fair Value Hierarchy (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-2-investments-and-fair-value-measurement-fair-value-of-financial-assets-and-liabilities-by-level-within-fair-value-hierarchy-details Note 2 - Investments and Fair Value Measurement - Fair Value of Financial Assets and Liabilities by Level Within Fair Value Hierarchy (Details) Details 43 false false R44.htm 043 - Disclosure - Note 2 - Investments and Fair Value Measurement - Summary of Changes in Fair Value of Level III Financial Liabilities (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-2-investments-and-fair-value-measurement-summary-of-changes-in-fair-value-of-level-iii-financial-liabilities-details Note 2 - Investments and Fair Value Measurement - Summary of Changes in Fair Value of Level III Financial Liabilities (Details) Details 44 false false R45.htm 044 - Disclosure - Note 3 - Inventories (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-3-inventories-details-textual Note 3 - Inventories (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-3-inventories-tables 45 false false R46.htm 045 - Disclosure - Note 3 - Inventories - Inventory Components (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-3-inventories-inventory-components-details Note 3 - Inventories - Inventory Components (Details) Details 46 false false R47.htm 046 - Disclosure - Note 4 - Property and Equipment (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-4-property-and-equipment-details-textual Note 4 - Property and Equipment (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-4-property-and-equipment-tables 47 false false R48.htm 047 - Disclosure - Note 4 - Property and Equipment - Components of Property and Equipment (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-4-property-and-equipment-components-of-property-and-equipment-details Note 4 - Property and Equipment - Components of Property and Equipment (Details) Details 48 false false R49.htm 048 - Disclosure - Note 5 - Revenue from Contracts with Customers (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-5-revenue-from-contracts-with-customers-details-textual Note 5 - Revenue from Contracts with Customers (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-5-revenue-from-contracts-with-customers-tables 49 false false R50.htm 049 - Disclosure - Note 5 - Revenue from Contracts with Customers - Disaggregation of Revenue (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-5-revenue-from-contracts-with-customers-disaggregation-of-revenue-details Note 5 - Revenue from Contracts with Customers - Disaggregation of Revenue (Details) Details 50 false false R51.htm 050 - Disclosure - Note 5 - Revenue from Contracts with Customers - Changes in Contract Liabilities (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-5-revenue-from-contracts-with-customers-changes-in-contract-liabilities-details Note 5 - Revenue from Contracts with Customers - Changes in Contract Liabilities (Details) Details 51 false false R52.htm 051 - Disclosure - Note 6 - Long-term Debt (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-6-longterm-debt-details-textual Note 6 - Long-term Debt (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-6-longterm-debt-tables 52 false false R53.htm 052 - Disclosure - Note 6 - Long-term Debt - Balance of Future Payments (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-6-longterm-debt-balance-of-future-payments-details Note 6 - Long-term Debt - Balance of Future Payments (Details) Details 53 false false R54.htm 053 - Disclosure - Note 6 - Long-term Debt - Balance of Future Payments (Details) (Parentheticals) Sheet http://www.acelrx.com/20191231/role/statement-note-6-longterm-debt-balance-of-future-payments-details-parentheticals Note 6 - Long-term Debt - Balance of Future Payments (Details) (Parentheticals) Details 54 false false R55.htm 054 - Disclosure - Note 6 - Long-term Debt - Outstanding Future Payments of Long-term Debt (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-6-longterm-debt-outstanding-future-payments-of-longterm-debt-details Note 6 - Long-term Debt - Outstanding Future Payments of Long-term Debt (Details) Details 55 false false R56.htm 055 - Disclosure - Note 7 - Leases (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-7-leases-details-textual Note 7 - Leases (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-7-leases-tables 56 false false R57.htm 056 - Disclosure - Note 7 - Leases - Operating Lease Costs (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-7-leases-operating-lease-costs-details Note 7 - Leases - Operating Lease Costs (Details) Details 57 false false R58.htm 057 - Disclosure - Note 7 - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-7-leases-maturities-of-lease-liabilities-details Note 7 - Leases - Maturities of Lease Liabilities (Details) Details 58 false false R59.htm 058 - Disclosure - Note 7 - Leases - Future Minimum Sublease Payments (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-7-leases-future-minimum-sublease-payments-details Note 7 - Leases - Future Minimum Sublease Payments (Details) Details 59 false false R60.htm 059 - Disclosure - Note 8 - Liability Related to Sale of Future Royalties (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-8-liability-related-to-sale-of-future-royalties-details-textual Note 8 - Liability Related to Sale of Future Royalties (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-8-liability-related-to-sale-of-future-royalties-tables 60 false false R61.htm 060 - Disclosure - Note 8 - Liability Related to Sale of Future Royalties - Activity of Liability Related to Sale of Future Royalties (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-8-liability-related-to-sale-of-future-royalties-activity-of-liability-related-to-sale-of-future-royalties-details Note 8 - Liability Related to Sale of Future Royalties - Activity of Liability Related to Sale of Future Royalties (Details) Details 61 false false R62.htm 061 - Disclosure - Note 9 - Warrants (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-9-warrants-details-textual Note 9 - Warrants (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-9-warrants 62 false false R63.htm 062 - Disclosure - Note 11 - Stockholders' Equity (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-11-stockholders-equity-details-textual Note 11 - Stockholders' Equity (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-11-stockholders-equity- 63 false false R64.htm 063 - Disclosure - Note 12 - Stock-based Compensation (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation-details-textual Note 12 - Stock-based Compensation (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation-tables 64 false false R65.htm 064 - Disclosure - Note 12 - Stock-based Compensation - Stock-based Compensation Expense (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation-stockbased-compensation-expense-details Note 12 - Stock-based Compensation - Stock-based Compensation Expense (Details) Details 65 false false R66.htm 065 - Disclosure - Note 12 - Stock-based Compensation - Restricted Stock Activity (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation-restricted-stock-activity-details Note 12 - Stock-based Compensation - Restricted Stock Activity (Details) Details 66 false false R67.htm 066 - Disclosure - Note 12 - Stock-based Compensation - Option Activity (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation-option-activity-details Note 12 - Stock-based Compensation - Option Activity (Details) Details 67 false false R68.htm 067 - Disclosure - Note 12 - Stock-based Compensation - Stock Options Outstanding, Vested and Exercisable (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation-stock-options-outstanding-vested-and-exercisable-details Note 12 - Stock-based Compensation - Stock Options Outstanding, Vested and Exercisable (Details) Details 68 false false R69.htm 068 - Disclosure - Note 12 - Stock-based Compensation - Assumptions to Calculate Fair Value of Each Employee Stock Option (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-12-stockbased-compensation-assumptions-to-calculate-fair-value-of-each-employee-stock-option-details Note 12 - Stock-based Compensation - Assumptions to Calculate Fair Value of Each Employee Stock Option (Details) Details 69 false false R70.htm 069 - Disclosure - Note 13 - Net Loss Per Share of Common Stock - Common Stock Excluded From Computation of Diluted Net Loss Per Share (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-13-net-loss-per-share-of-common-stock-common-stock-excluded-from-computation-of-diluted-net-loss-per-share-details Note 13 - Net Loss Per Share of Common Stock - Common Stock Excluded From Computation of Diluted Net Loss Per Share (Details) Details 70 false false R71.htm 070 - Disclosure - Note 14 - Accrued Liabilities - Accrued Liabilities (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-14-accrued-liabilities-accrued-liabilities-details Note 14 - Accrued Liabilities - Accrued Liabilities (Details) Details 71 false false R72.htm 071 - Disclosure - Note 15 - 401(k) Plan (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-15-401k-plan-details-textual Note 15 - 401(k) Plan (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-15-401k-plan 72 false false R73.htm 072 - Disclosure - Note 16 - Income Taxes (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-16-income-taxes-details-textual Note 16 - Income Taxes (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-16-income-taxes-tables 73 false false R74.htm 073 - Disclosure - Note 16 - Income Taxes - Net Deferred Tax Assets (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-16-income-taxes-net-deferred-tax-assets-details Note 16 - Income Taxes - Net Deferred Tax Assets (Details) Details 74 false false R75.htm 074 - Disclosure - Note 16 - Income Taxes - Reconciliation of Statutory Federal Income Tax (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-16-income-taxes-reconciliation-of-statutory-federal-income-tax-details Note 16 - Income Taxes - Reconciliation of Statutory Federal Income Tax (Details) Details 75 false false R76.htm 075 - Disclosure - Note 16 - Income Taxes - Reconciliation of Beginning and Ending Balance of Unrecognized Tax Benefits (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-16-income-taxes-reconciliation-of-beginning-and-ending-balance-of-unrecognized-tax-benefits-details Note 16 - Income Taxes - Reconciliation of Beginning and Ending Balance of Unrecognized Tax Benefits (Details) Details 76 false false R77.htm 076 - Disclosure - Note 17 - Subsequent Event (Details Textual) Sheet http://www.acelrx.com/20191231/role/statement-note-17-subsequent-event-details-textual Note 17 - Subsequent Event (Details Textual) Details http://www.acelrx.com/20191231/role/statement-note-17-subsequent-event 77 false false R78.htm 077 - Disclosure - Note 18 - Unaudited Quarterly Financial Data - Quarterly Financial Data (Details) Sheet http://www.acelrx.com/20191231/role/statement-note-18-unaudited-quarterly-financial-data-quarterly-financial-data-details Note 18 - Unaudited Quarterly Financial Data - Quarterly Financial Data (Details) Details 78 false false All Reports Book All Reports acrx-20191231.xml acrx-20191231.xsd acrx-20191231_cal.xml acrx-20191231_def.xml acrx-20191231_lab.xml acrx-20191231_pre.xml http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true